Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAIVE: Ivermectin for COVID-19 Prevention
NCT05305560Phase 2Completed
- Sponsor
- MedinCell
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by MedinCell. Started Mar 2022; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05305560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305560.